Solid Biosciences获得FDA快速通道资格,用于针对CPVT的基因疗法Solid Biosciences Receives FDA Fast Track Designation for Gene Therapy Targeting CPVT

动脉网
24 Jul

Solid Biosciences Inc. has received Fast Track designation from the US Food and Drug Administration (FDA) for its investigational gene therapy, SGT-501.Solid Biosciences Inc. 公司的在研基因疗法 SGT-501 获得了美国食品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10